Temozolomide-associated hypermutation in gliomasSerah Choi, J Costello, Yu Yao et al.|Neuro-Oncology|2018Cited by 227
Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade <i>IDH</i>-mutant gliomasYu Yao, Nancy Ann Oberheim Bush, David A. Solomon et al.|Neuro-Oncology|2021Cited by 127
PATH-12. TEMOZOLOMIDE-INDUCED HYPERMUTATION IS ASSOCIATED WITH HIGH-GRADE TRANSFORMATION, DISTANT RECURRENCE AND REDUCED SURVIVAL IN INITIALLY LOW GRADE IDH-MUTANT GLIOMASYu Yao, Nancy Ann Oberheim Bush, Javier Villanueva‐Meyer et al.|Neuro-Oncology|2020Cited by 2
PATH-29. CLINICAL SIGNIFICANCE OF TEMOZOLOMIDE-INDUCED SOMATIC HYPERMUTATION IN INITIALLY LOW-GRADE IDH-MUTANT DIFFUSE GLIOMASYu Yao, Nancy Ann Oberheim Bush, Stephanie Hilz et al.|Neuro-Oncology|2018Cited by 0